Dr. Hudalla is a Ph.D. analytical chemist with more than 25 years of research experience in analytical chemistry, spectroscopy and chromatographic method development. He is recognized worldwide as an expert in the field of traditional Reverse Phase Liquid, Supercritical Fluid and Convergence Chromatography and an active leader in the development and implementation of the UltraPerformance Convergence Chromatography instrumentation. Dr. Hudalla is a founder and Chief Scientific Officer of ProVerde Laboratories, Inc., a premier analytical testing, CO2 extraction and derivative product formulation consultancy for the regulated medical cannabis and hemp industries. ProVerde is one of few laboratories in the U.S. to receive an ISO 17025 accreditation that specifically governs medical cannabis testing. ProVerde Laboratories operates at the cutting edge of medical cannabis extraction, purification and product formulation techniques, supported by expert analytical testing, with expertise that will move research into cannabis and its effects on various medical conditions forward as the medical cannabis industry progresses. Dr. Hudalla plays an integral part in providing clients operating in the Medical Marijuana and hemp industries the ability to deliver new products and product formulations that meet the highest standards for quality, consistency, safety and labeling. Dr. Hudalla received his M.S. and Ph.D. from the University of California at Santa Barbara and was a Postdoctoral Fellow at the Eppley Institute for Cancer Research within the University of Nebraska Medical Center. Dr. Hudalla has delivered presentations all over the world in his areas of expertise, including analytical testing and research specific to medical cannabis and serves on the Cannabis Expert Panel with the United States Pharmacopeia (USP).